• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三大洲 379257 名受者的肾脏移植移植物结局。

Kidney transplant graft outcomes in 379 257 recipients on 3 continents.

机构信息

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

University of Michigan, Ann Arbor, MI, USA.

出版信息

Am J Transplant. 2018 Aug;18(8):1914-1923. doi: 10.1111/ajt.14694. Epub 2018 Mar 24.

DOI:10.1111/ajt.14694
PMID:29573328
Abstract

Kidney transplant outcomes that vary by program or geopolitical unit may result from variability in practice patterns or health care delivery systems. In this collaborative study, we compared kidney graft outcomes among 4 countries (United States, United Kingdom, Australia, and New Zealand) on 3 continents. We analyzed transplant and follow-up registry data from 1988-2014 for 379 257 recipients of first kidney-only transplants using Cox regression. Compared to the United States, 1-year adjusted graft failure risk was significantly higher in the United Kingdom (hazard ratio [HR] 1.22, 95% confidence interval [CI] 1.18-1.26, P < .001) and New Zealand (hazard ratio [HR] 1.29, 95% confidence interval [CI] 1.14-1.46, P < .001), but lower in Australia (HR 0.90, 95% CI 0.84-0.96, P = .001). In contrast, long-term adjusted graft failure risk (conditional on 1-year function) was significantly higher in the United States compared to Australia, New Zealand, and the United Kingdom (HR 0.74, 0.75, and 0.74, respectively; each P < .001). Thus long-term kidney graft outcomes are approximately 25% worse in the United States than in 3 other countries with well-developed kidney transplant systems. Case mix differences and residual confounding from unmeasured factors were found to be unlikely explanations. These findings suggest that identification of potentially modifiable country-specific differences in care delivery and/or practice patterns should be sought.

摘要

肾移植结果因项目或地缘政治单位而异,可能源于实践模式或医疗保健提供系统的差异。在这项合作研究中,我们比较了来自三个大洲的四个国家(美国、英国、澳大利亚和新西兰)的肾移植结果。我们使用 Cox 回归分析了 1988 年至 2014 年期间 379257 名首次单肾移植受者的移植和随访登记数据。与美国相比,英国(危险比 [HR] 1.22,95%置信区间 [CI] 1.18-1.26,P<0.001)和新西兰(HR 1.29,95%CI 1.14-1.46,P<0.001)的 1 年调整后移植物失败风险显著更高,但澳大利亚(HR 0.90,95%CI 0.84-0.96,P=0.001)的风险较低。相比之下,与澳大利亚、新西兰和英国相比,美国的长期调整后移植物失败风险(1 年功能条件下)显著更高(HR 分别为 0.74、0.75 和 0.74,均 P<0.001)。因此,与 3 个具有发达肾移植系统的其他国家相比,美国的长期肾移植结果约差 25%。发现病例组合差异和未测量因素引起的残余混杂不太可能是解释。这些发现表明,应寻求确定潜在的可改变的特定国家的护理提供和/或实践模式差异。

相似文献

1
Kidney transplant graft outcomes in 379 257 recipients on 3 continents.三大洲 379257 名受者的肾脏移植移植物结局。
Am J Transplant. 2018 Aug;18(8):1914-1923. doi: 10.1111/ajt.14694. Epub 2018 Mar 24.
2
Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study.受者合并症与肾移植后生存结局:英国范围前瞻性队列研究。
Transplantation. 2020 Jun;104(6):1246-1255. doi: 10.1097/TP.0000000000002931.
3
Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.活体供肾移植受者的长时间缺血时间、移植肾功能延迟恢复以及移植肾和患者的预后
Am J Transplant. 2016 Sep;16(9):2714-23. doi: 10.1111/ajt.13817. Epub 2016 May 5.
4
Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis.移植前恶性肿瘤对肾移植后结局的影响:美国器官共享网络数据库分析。
J Am Coll Surg. 2019 Dec;229(6):568-579. doi: 10.1016/j.jamcollsurg.2019.06.001. Epub 2019 Oct 27.
5
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.糖尿病对移植前血管疾病与肾移植后长期移植和患者结局关联的影响:一项基于人群的队列研究。
Am J Kidney Dis. 2018 Jan;71(1):102-111. doi: 10.1053/j.ajkd.2017.08.018. Epub 2017 Nov 28.
6
Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.美国肾移植受者患肾细胞癌的风险
Am J Transplant. 2016 Dec;16(12):3479-3489. doi: 10.1111/ajt.13862. Epub 2016 Jun 23.
7
Waiting Time Between Failure of First Graft and Second Kidney Transplant and Graft and Patient Survival.首次移植失败至第二次肾移植之间的等待时间以及移植肾和患者的存活率。
Transplantation. 2016 Aug;100(8):1767-75. doi: 10.1097/TP.0000000000000953.
8
Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.肾移植前后的处方阿片类药物使用:对移植后结局的影响。
Am J Transplant. 2018 Dec;18(12):2987-2999. doi: 10.1111/ajt.14714. Epub 2018 Apr 17.
9
Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.美国活体供肾移植受者中来自供体后代的肾脏有更好的移植物结局。
Am J Transplant. 2019 Jan;19(1):269-276. doi: 10.1111/ajt.15126. Epub 2018 Oct 16.
10
Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death.小儿肾移植受者的肥胖与急性排斥反应、移植物丢失及死亡风险
Pediatr Nephrol. 2017 Aug;32(8):1443-1450. doi: 10.1007/s00467-017-3636-1. Epub 2017 Mar 30.

引用本文的文献

1
Preimplantation Histopathologic Assessment of Deceased Donor Kidneys: Recommendations from the Banff Time-Zero Biopsy Working Group.deceased供体肾脏的植入前组织病理学评估:班夫零时间活检工作组的建议
J Am Soc Nephrol. 2025 Jul 14. doi: 10.1681/ASN.0000000820.
2
Role of Educational Level in Kidney Transplant Outcomes.教育水平在肾移植结果中的作用。
Biomedicines. 2025 Apr 9;13(4):916. doi: 10.3390/biomedicines13040916.
3
A Transplant-Inclusive Value-Based Kidney Care Payment Model.一种包含移植的基于价值的肾脏护理支付模式。
Kidney Int Rep. 2024 Feb 9;9(6):1590-1600. doi: 10.1016/j.ekir.2024.02.004. eCollection 2024 Jun.
4
Predictive Factors of Renal Graft Failure in Tunisian Children and young adults: A Retrospective Study.预测突尼斯儿童和青年肾移植失败的因素:一项回顾性研究。
Tunis Med. 2024 Jan 5;102(1):38-43. doi: 10.62438/tunismed.v102i1.4328.
5
Myosteatosis is associated with poor survival after kidney transplantation: a large retrospective cohort validation.肌肉脂肪变性与肾移植后生存率差相关:一项大型回顾性队列验证。
Abdom Radiol (NY). 2024 Apr;49(4):1210-1222. doi: 10.1007/s00261-023-04180-w. Epub 2024 Feb 7.
6
A nationwide study of regional preference and graft survival of kidney transplantation in South Korea: patterns of centralization in the capital area.韩国肾脏移植区域偏好与移植肾存活的全国性研究:首都地区的集中化模式
Ann Surg Treat Res. 2024 Jan;106(1):11-18. doi: 10.4174/astr.2024.106.1.11. Epub 2023 Dec 28.
7
Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review.肾移植受者临床试验报告的心血管结局范围与一致性:一项系统评价
Transplant Direct. 2022 Dec 7;9(1):e1398. doi: 10.1097/TXD.0000000000001398. eCollection 2023 Jan.
8
Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation.BEST-液体试验参与者的基线特征及代表性:一项关于平衡晶体溶液与生理盐水在 deceased 供体肾移植中对比的随机试验
Transplant Direct. 2022 Nov 4;8(12):e1399. doi: 10.1097/TXD.0000000000001399. eCollection 2022 Dec.
9
Major adverse cardiovascular events and all-cause mortality after emergency general surgery among kidney failure patients.肾衰竭患者接受急诊普通外科手术后的主要心血管不良事件和全因死亡率。
BJS Open. 2022 Nov 2;6(6). doi: 10.1093/bjsopen/zrac130.
10
Deceased Donor Characteristics and Kidney Transplant Outcomes.已故供体特征与肾脏移植结局。
Transpl Int. 2022 Aug 25;35:10482. doi: 10.3389/ti.2022.10482. eCollection 2022.